Literature DB >> 34036651

SARS-CoV-2 mRNA vaccine-associated fixed drug eruption.

D Mintoff1, D Pisani2, A Betts2, L Scerri1.   

Abstract

Entities:  

Year:  2021        PMID： 34036651     DOI： 10.1111/jdv.17390

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN： 0926-9959            Impact factor:   6.166


× No keyword cloud information.
  10 in total

1.  A case of bullous pemphigoid after the SARS-CoV-2 mRNA vaccine.

Authors:  J Young; L Mercieca; M Ceci; D Pisani; A Betts; M J Boffa
Journal:  J Eur Acad Dermatol Venereol       Date:  2021-10-05       Impact factor: 9.228

2.  Generalized bullous fixed drug eruption after Oxford-AstraZeneca (ChAdOx1 nCoV-19) vaccination.

Authors:  K Wantavornprasert; N Noppakun; J Klaewsongkram; P Rerknimitr
Journal:  Clin Exp Dermatol       Date:  2021-10-10       Impact factor: 4.481

Review 3.  Cutaneous and hypersensitivity reactions associated with COVID-19 vaccination-a narrative review.

Authors:  Uwe Wollina; Anca Chiriac; Hristina Kocic; André Koch; Piotr Brzezinski
Journal:  Wien Med Wochenschr       Date:  2021-08-23

4.  Fixed drug eruption after Pfizer-BioNTech COVID-19 vaccine: A case report.

Authors:  Elodie Lellig; Claudie Mouton-Faivre; Diane Abs; Anne-Claire Bursztejn
Journal:  J Allergy Clin Immunol Pract       Date:  2022-04-22

Review 5.  SARS-CoV-2 vaccine-related cutaneous manifestations: a systematic review.

Authors:  Gianluca Avallone; Pietro Quaglino; Francesco Cavallo; Gabriele Roccuzzo; Simone Ribero; Iris Zalaudek; Claudio Conforti
Journal:  Int J Dermatol       Date:  2022-02-09       Impact factor: 3.204

6.  Generalized and persistent skin pigmentation after COVID-19 vaccination.

Authors:  J Lu; Y Liu; Y Sun
Journal:  J Eur Acad Dermatol Venereol       Date:  2022-06-30       Impact factor: 9.228

7.  A case of recurrent fixed drug eruption following two different coronavirus disease 2019 vaccination verified through intradermal and patch tests.

Authors:  Jung Eun Seol; Sang Woo Ahn; Seung Hee Jang; Seong Min Hong; Mi Yeong Kim; Hyojin Kim
Journal:  JAAD Case Rep       Date:  2022-08-27

8.  Common pitfalls and bias learned from the COVID-19 pandemic: Keeping a clear mind of judgment.

Authors:  Yng Sun; Cheng-Che E Lan; Ting-Ting Yang; Szu-Hao Chiu
Journal:  JAAD Case Rep       Date:  2022-07-02

Review 9.  COVID-19 vaccines: What dermatologists should know?

Authors:  Azin Ayatollahi; Hamed Hosseini; Rojin Firooz; Alireza Firooz
Journal:  Dermatol Ther       Date:  2021-07-13       Impact factor: 3.858

10.  Another case of generalized bullous fixed drug eruption following an adenoviral vector-based COVID-19 vaccine (ChAdOx1 nCov-19).

Authors:  C Ben Salem; A Khelif; D Sahnoun; N Ghariani; B Sriha; M Denguezli
Journal:  J Eur Acad Dermatol Venereol       Date:  2022-03-15       Impact factor: 9.228
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.